Modern and promising therapies for postherpetic neuralgia

Postherpetic neuralgia (PHN) is highly prevalent among the elderly and immunocompromised patients and decreases patients' quality of life. Currently, much attention is paid to the prevention of this disease and the development of new therapies and treatment approaches. The article discusses new targets for treating this type of pain, both pharmacotherapy and invasive methods. Analysis of clinical trials shows that a combination of different therapies can improve symptom management and patients' quality of life. It was shown that the earlier the treatment of PHN begins, the higher the probability of gaining control over the pain severity. The article emphasizes the need for further research to optimize approaches to PHN treatment and raise the medical community's awareness about new treatment options.